UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Index funds often deliver steady returns due to broad diversification and low costs; learn how this supports long-term growth.
25,349 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Petco's WOOF ticker hints at a pet retailer balancing stores, services, and digital growth. This investor guide break...
A leading analyst signals more upside for CVS Health as Medicare-related momentum builds. Learn the key drivers, risk...
Qualcomm just outlined a much larger growth plan, signaling a strong bet on AI beyond smartphones. This deep dive exp...
Investors often wonder if XRP is priced high what actually delivers today. This guide breaks down XRPL capabilities, ...
Investors want to know if now is the time figma stock? This guide breaks down how to evaluate Figma stock, what metri...
As NIO reports its first quarterly profit, the market weighs durability vs. growth. This in-depth look breaks down ho...
Deficits are mounting as the Treasury plots heavy borrowing for the current and next fiscal years. Officials project ...
This article breaks down agilysys (agys) 2026 earnings, explaining what the metrics mean for investors. Learn how to ...
Morgan’s Analyst Focus List for June highlights five top passive-income dividend ideas, signaling a cautious but inco...
May pending home sales showed a notable uptick despite higher borrowing costs. The NAR report shows gains across regi...
Is Lilly stock undervalued healthcare? This article breaks down the valuation case, growth catalysts, risks, and a pr...